XOMA

XOMA is a biotechnology royalty aggregator that plays a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economic benefits associated with pre-commercial and commercial candidate therapies that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires these future economics, the seller receives non-dilutive, non-recourse capital that they can use to advance their internal drug candidates or for general corporate purposes. The company has a broad and growing portfolio with over 70 assets (an asset is defined as the right to receive potential future economic benefits related to the progress of a potential therapeutic candidate).